MedPath

Tailored to You (TTY) Pilot Study

Not Applicable
Completed
Conditions
Hypertension
Registration Number
NCT05141175
Lead Sponsor
Duke University
Brief Summary

The purpose of this research study is to use a test called impedance cardiography (ICG) to provide more information about how to improve the control of blood pressure. Participants will be given this test so investigators can get more information about what is going on inside the heart and blood vessels that is contributing to high blood pressure. ICG is a lot like an EKG (electrocardiogram) in that it uses electrodes and a computer to make a report. Participants will lie down on the exam table and two electrodes go on the right ankle and two electrodes go on the left wrist. The process takes about 5 minutes and is painless and not invasive.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Documented diagnosis of hypertension
  • Most recent office systolic BP average measured using automated office BP (AOBP) is ≥140 mmHg systolic or ≥90 mmHg diastolic
  • Currently prescribed at least one BP-lowering medication
  • Under the care of a primary care clinician
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of Participants That Completed Study as Measured by Enrollment Logs1.5 months
Number of Participants Enrolled as Measured by Enrollment Logs1.5 months
Secondary Outcome Measures
NameTimeMethod
Change in Blood Pressure as Measured by Medical RecordBaseline, 4 months
Number of Anti-hypertensive Medications Prescribed as Measured by Medical Record ReviewUp to 4 months

Trial Locations

Locations (1)

Duke Primary Care

🇺🇸

Durham, North Carolina, United States

Duke Primary Care
🇺🇸Durham, North Carolina, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.